Heat Biologics, Inc. (NASDAQ:HTBX) added $0.13 to its price during the regular trading session on Wednesday, reaching $2.25. When it comes to volume, 2.21 million shares of this company’s common stock changed hands. Heat Biologics, Inc. (NASDAQ:HTBX) has experienced a 1-year low price of $1.09 and a 1-year high price of $7.89. This organization’s current debt-to-equity ratio is 0.00, its current ratio is 1.10 and its quick ratio is 1.10 at the time of writing. The company has a beta of 1.03.

ROTH Capital Initiated shares of Heat Biologics, Inc. (NASDAQ:HTBX) to a Buy rating in a report posted on Monday, June 20th, 2016. Several additional equities analysts have also published recent reports on HTBX stock. Noble Financial, for example, Initiated Heat Biologics, Inc. to Buy in a report that was made public on Friday, January 8th, 2016. H.C. Wainwright Initiated a $13 price target on Heat Biologics, Inc. in a report from Tuesday, May 26th, 2015, while giving the stock to a Buy rating. In a report sent out on Wednesday, September 18th, 2013, Aegis Capital Initiated the stock rating on Heat Biologics, Inc. to a Buy.

There is a technical analysis indicator called the Relative Strength Index, or RSI, and analysts use it to measure momentum within a range of 0 to 100. When a stock’s RSI falls under 30, it is considered to be oversold. For Heat Biologics, Inc., specifically, the RSI metric has reached 53.09. Heat Biologics, Inc. (NASDAQ:HTBX) has gained 1.35% in value over the last three months, and -35.75% over the last six-month period. Over the last full year, the stock price has lost -64.95%.

The measurement of a stock’s predictable daily price range is referred to as volatility – and it’s also the price range within which a day trader does his or her business. Higher volatility translates to higher losses or profits. After recently verifying the number, Heat Biologics, Inc. (NASDAQ:HTBX) stock has a volatility measurement of 13.92% for the week, with 11.62% volatility as observed from the past 30 days. The public company has 5.80M shares outstanding currently, as well as a market cap of $13.05M. This stock’s distance from its 20-day simple moving average is 1.19%, based on a recent bid, while its distance from the 50-day simple moving average is currently 29.60%. Meanwhile, it has a distance of -39.43% from the 200-day simple moving average. Today, this organization is sitting -71.48% away from its 52-week high price and 106.42% away from its 52-week low price.

More detail-oriented stock traders might be keeping tabs on another metric: the Williams Percent Range or Williams %R. The Williams %R measurement is a widely-used technical indicator founded by Larry Williams to enable the identification of oversold and overbought stock territory. Traders will typically use Williams %R alongside other trend indicators to help locate potential turning points in a stock’s price trajectory. Heat Biologics, Inc. (NASDAQ:HTBX)’s Williams Percent Range, or 14-day Williams %R, is sitting at 54.48 at the time of writing. Generally speaking, if the indicator rises above -20, the shares may be overbought. On the flip side, if the indicator goes below -80, it may mean that the stock has crossed over into oversold territory.

Investors oftentimes keep their eyes on the latest stock price support and resistance levels. The support is a lower “floor” level where a stock may bounce back after it has dipped. If the share price can penetrate the first support level, investor attention may shift to the second level. The resistance is the contrary of support levels. As a stock grows in value, it may see a dip once it reaches a specific level of resistance. After a recent examination, this company’s shares’ first resistance level is sitting at 2.36. Meanwhile, investors are looking out for the first support level, which is 2.07.